Mustang Bio, Inc.
MBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680048
No open-market purchases or sales by Mustang Bio, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $378.3K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Mustang Bio, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +5 vs. Q3 2025
- Shares held
- 552.0K
- +271.4K (+96.7%) vs. Q3 2025
- Total value
- $541.9K
- +$115.4K (+27.0%) vs. Q3 2025
- New holders
- 7
- 6 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $378.3K |
| Q1 2026 | 22 | $369.8K |
| Q4 2025 | 25 | $541.9K |
| Q3 2025 | 20 | $426.5K |
| Q2 2025 | 17 | $70.9K |
| Q1 2025 | 16 | $142.3K |
| Q4 2024 | 30 | $826.5K |
| Q3 2024 | 25 | $207.2K |
| Q2 2024 | 29 | $372.6K |
| Q1 2024 | 30 | $773.1K |
| Q4 2023 | 28 | $1.40M |
| Q3 2023 | 27 | $1.22M |
| Q2 2023 | 28 | $3.94M |
| Q1 2023 | 52 | $3.62M |
| Q4 2022 | 66 | $4.71M |
| Q3 2022 | 70 | $6.80M |
| Q2 2022 | 77 | $10.3M |
| Q1 2022 | 85 | $25.3M |
| Q4 2021 | 88 | $46.4M |
| Q3 2021 | 83 | $71.8M |
| Q2 2021 | 98 | $85.9M |
| Q1 2021 | 99 | $80.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Mustang Bio, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kestra Advisory Services, LLC | 111,042 | $108.9K | 0.00% | +44,934+68.0% | Added |
| Citadel Advisors LLC | 84,765 | $83.2K | 0.00% | +84,765 | New |
| BlackRock, Inc. | 84,745 | $83.1K | 0.00% | 00.0% | Unchanged |
| DRW Securities, LLC | 73,936 | $72.5K | 0.01% | +73,936 | New |
| Vanguard Group Inc | 57,863 | $56.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 40,034 | $39.3K | 0.00% | +40,034 | New |
| Geode Capital Management, LLC | 32,285 | $31.7K | 0.00% | +5,867+22.2% | Added |
| XTX Topco Ltd | 24,073 | $23.6K | 0.00% | +5,298+28.2% | Added |
| Jane Street Group, LLC | 14,126 | $13.9K | 0.00% | +14,126 | New |
| Gsa Capital Partners LLP | 12,834 | $13.0K | 0.00% | +12,834 | New |
| CFO4Life Group, LLC | 12,961 | $12.7K | 0.00% | +2,500+23.9% | Added |
| SBI Securities Co., Ltd. | 2,009 | $1.97K | 0.00% | +2+0.1% | Added |
| Tower Research Capital LLC (TRC) | 936 | $918 | 0.00% | −396−29.7% | Reduced |
| Morgan Stanley | 153 | $150 | 0.00% | −150−49.5% | Reduced |
| Harbour Investments, Inc. | 76 | $75 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $53 | 0.00% | +2+3.8% | Added |
| UBS Group AG | 44 | $43 | 0.00% | −4−8.3% | Reduced |
| Cullen/Frost Bankers, Inc. | 13 | $13 | 0.00% | +13 | New |
| BNP Paribas Arbitrage, SA | 6 | $6 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 3 | $3 | 0.00% | +3 | New |
| NBC Securities, Inc. | 3 | $2 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −602−100.0% | Sold out |